CDC approves booster shots for millions of Americans: In a rare move, CDC Director Dr. Rochelle Walensky said those who have jobs that make them vulnerable to COVID exposure can also get the extra doses. Read more COVID vaccines well worth it for cancer patients: A pair of clinical trialsContinue Reading

Here are some of HealthDay’s top stories for Wednesday, Sept. 22: Pregnant women, do your baby a favor and get a COVID vaccine: A new study found that mothers-to-be who had either the Pfizer or Moderna shots passed high levels of antibodies to their infants. Read more CDC advisory panelContinue Reading

Here are some of HealthDay’s top stories for Tuesday, Sept. 21: Pandemic has changed what and how families eat: A new poll shows half are cooking at home more often and two-thirds are making healthier food choices. But 20% of parents, many of whom said they felt stressed, are pickingContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — Millions of U.S. sleep apnea patients are scrambling to find ways to protect their nightly slumber, following a voluntary recall from one of the nation’s leading manufacturers of CPAP breathing machines. Philips Respironics agreed to a voluntary recall of continuous positive airway pressureContinue Reading

Here are some of HealthDay’s top stories for Monday, Sept. 20: Lower dose of Pfizer vaccine works in kids as young as 5: The pharmaceutical giant announced Monday that a dose that is one-third the strength of adult doses triggered a robust immune response in young children. Read more GoodContinue Reading

FRIDAY, Sept. 17, 2021 (HealthDay News) — Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or aboveContinue Reading

Here are some of HealthDay’s top stories for Friday, Sept. 17: FDA advisory panel meets on need for COVID-19 booster shots. Presented with evidence seemingly pro and con, an advisory committee to the U.S. Food and Drug Administration will convene Friday to decide whether or not Pfizer-BioNTech vaccine booster shotsContinue Reading

Here are some of HealthDay’s top stories for Thursday, Sept. 16: NIH spending nearly $470 million on long-haul COVID study. “Some people have had their lives completely upended by the major long-term effects of COVID-19,” said Dr. Francis Collins, director of the National Institutes of Health. A major research initiativeContinue Reading

Here are some of HealthDay’s top stories for Monday, Sept. 13: 9/11 first responders have higher odds for cancer 20 years later. It’s an event seared onto Americans’ memories, but studies show the destruction of the World Trade Center two decades ago is leaving a lasting legacy of cancer inContinue Reading